Jonathan Siegal
Comptroller/Controller/Auditor bei VERICEL CORPORATION
Vermögen: 63 630 $ am 30.04.2024
Profil
Jonathan D.
Siegal is currently working as the Chief Accounting Officer, VP & Controller at Vericel Corp.
Prior to his current position, he worked as the Global Controller at Lantheus Medical Imaging, Inc. from 2016 to 2021.
Mr. Siegal completed his undergraduate degree at Gordon College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VERICEL CORPORATION
0,00% | 07.03.2024 | 1 400 ( 0,00% ) | 63 630 $ | 30.04.2024 |
Aktive Positionen von Jonathan Siegal
Unternehmen | Position | Beginn |
---|---|---|
VERICEL CORPORATION | Comptroller/Controller/Auditor | - |
Ehemalige bekannte Positionen von Jonathan Siegal
Unternehmen | Position | Ende |
---|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Comptroller/Controller/Auditor | 01.01.2021 |
Ausbildung von Jonathan Siegal
Gordon College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Private Unternehmen | 1 |
---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |